Amplio Pharma AB
Methotrexate Forte – an innovation towards its clinical proof of concept
Status
IP Type
PCT
Time
14 years
Countries
Coverage
Claims
1. An immediate release pharmaceutical composition comprising (i) a therapeutic amount of methotrexate or any pharmaceutically acceptable salts thereof, (ii) a non-therapeutic amount of novobiocin or any pharmaceutically acceptable salts thereof, optionally in the association with one or more pharmaceutically acceptable excipient, carrier or diluent.
with dependent claims describing details on the formulation and its use in treatment of disease
Know more of this patent
This information is confidential, do not share or copy.
You can visit their website or
Under evaluation at least till: 21st of February 2023
KEEP REVIEWING